Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms.

Smolkova B, Kataki A, Earl J, Ruz-Caracuel I, Cihova M, Urbanova M, Buocikova V, Tamargo S, Rovite V, Niedra H, Schrader J, Kohl Y

Open source

DOI: 10.1016/j.critrevonc.2022.103865
Published: 2022 Dec
Container: Critical reviews in oncology/hematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.critrevonc.2022.103865,
  title = {Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms.},
  author = {Smolkova B and Kataki A and Earl J and Ruz-Caracuel I and Cihova M and Urbanova M and Buocikova V and Tamargo S and Rovite V and Niedra H and Schrader J and Kohl Y},
  year = {2022},
  journal = {Critical reviews in oncology/hematology},
  doi = {10.1016/j.critrevonc.2022.103865},
  url = {https://doi.org/10.1016/j.critrevonc.2022.103865}
}

RIS

TY  - JOUR
TI  - Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms.
AU  - Smolkova B
AU  - Kataki A
AU  - Earl J
AU  - Ruz-Caracuel I
AU  - Cihova M
AU  - Urbanova M
AU  - Buocikova V
AU  - Tamargo S
AU  - Rovite V
AU  - Niedra H
AU  - Schrader J
AU  - Kohl Y
PY  - 2022
JO  - Critical reviews in oncology/hematology
DO  - 10.1016/j.critrevonc.2022.103865
UR  - https://doi.org/10.1016/j.critrevonc.2022.103865
ER  -

APA

B, S., A, K., J, E., I, R., M, C., M, U., V, B., S, T., V, R., H, N., J, S., & Y, K. (2022). Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2022.103865

Source records

pubmed · retrieved 2026-09-27T00:37:19.360Z